Holen Sie sich die Stockscreener-App
1.23
0.81%
-0.01
Schlusskurs vom Vortag:
$1.24
Offen:
$1.2663
24-Stunden-Volumen:
26,061
Relative Volume:
0.35
Marktkapitalisierung:
$4.27M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.29M
KGV:
-0.2365
EPS:
-5.2
Netto-Cashflow:
$-9.42M
1W Leistung:
+6.97%
1M Leistung:
+17.14%
6M Leistung:
-51.95%
1J Leistung:
-64.38%
1-Tages-Spanne:
$1.21
$1.2663
1-Wochen-Bereich:
$1.06
$1.30
52-Wochen-Spanne:
$0.86
$6.18
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile
Firmenname
Scinai Immunotherapeutics Ltd Adr
Sektor
Branche
Telefon
972-8-9302529
Adresse
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM
Vergleichen Sie SCNI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCNI
Scinai Immunotherapeutics Ltd Adr
|
1.23 | 4.30M | 0 | -9.29M | -9.42M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Scinai Immunotherapeutics Ltd Adr Aktie (SCNI) Neueste Nachrichten
Scinai Immunotherapeutics (NASDAQ:SCNI) Shares Up 3% – What’s Next? - Defense World
Scinai Immunotherapeutics Reports Growth and Pipeline Progress - TipRanks
Scinai reports revenue growth as CDMO business expands By Investing.com - Investing.com India
Scinai reports revenue growth as CDMO business expands - Investing.com
Revenue per share of Scinai Immunotherapeutics Ltd. Sponsored ADR – MUN:2F5 - TradingView
SCNI | Scinai Immunotherapeutics Ltd. ADR SEC Filings - MarketWatch
Scinai Immunotherapeutics schedules annual meeting for December 22 - Investing.com
Scinai Immunotherapeutics schedules annual meeting for December 22 By Investing.com - Investing.com South Africa
Cash per share of Scinai Immunotherapeutics Ltd. Sponsored ADR – BER:2F5 - TradingView
Scinai receives $246,000 grant to expand biotech manufacturing By Investing.com - Investing.com South Africa
Scinai receives $246,000 grant to expand biotech manufacturing - Investing.com
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports First-Half 2025 Results, Strengthened Cash Position - Barchart.com
Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet - Barchart.com
Scinai Immunotherapeutics (NASDAQ:SCNI) Trading Down 3.8% – Here’s What Happened - Defense World
Scinai Immunotherapeutics Ltd ADR (SCNI) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Scinai Immunotherapeutics (NASDAQ: SCNI) Publishes Peer-Reviewed Data Supporting PC111 as Potential Disease Modifier - Barchart.com
Scinai Immunotherapeutics stock soars on promising skin disease drug data By Investing.com - Investing.com South Africa
Scinai Immunotherapeutics stock soars on promising skin disease drug data - Investing.com Australia
Scinai’s PC111 antibody shows promise for pemphigus treatment By Investing.com - Investing.com Canada
Scinai’s PC111 antibody shows promise for pemphigus treatment - Investing.com India
ICICI Bank Ltd. ADR (IBN) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN - Benzinga
Scinai Immunotherapeutics (SCNI) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat
Augusta Gold (TSE:G) Shares Pass Below Two Hundred Day Moving Average – Time to Sell? - Defense World
Scinai Immunotherapeutics Faces Financial Challenges, Seeks Growth - TipRanks
Scinai Immunotherapeutics Reports Strong CDMO Growth - TipRanks
Scinai Immunotherapeutics (NASDAQ: SCNI) Enters Option Agreement to Acquire Italian Biotech Pincell - The Globe and Mail
Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - The Globe and Mail
Scinai regains Nasdaq compliance, eyes EIB loan conversion - Investing.com
Scinai Immunotherapeutics (SCNI) Stock Forecast and Price Target 2025 - MarketBeat
Scinai Immunotherapeutics enacts reverse split to meet Nasdaq rules - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Scinai Immunotherapeutics (SCNI) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
Scinai Immunotherapeutics Ltd. Sponsored ADR Cash Flow – NASDAQ:SCNI - TradingView
Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Participation at BIO-Europe Munich 2023 - Barchart.com
Scinai Immunotherapeutics (SCNI) Institutional Ownership 2025 - MarketBeat
SCNI Stock Price and Chart — NASDAQ:SCNI - TradingView
Scinai Immunotherapeutics (SCNI) Stock Price, News & Analysis - MarketBeat
Scinai Immunotherapeutics Ltd Share Price ADR Each Representing 400 Ord Shares SPON - Hargreaves Lansdown
SCNIScinai Immunotherapeutics Ltd ADR Stock Price and Quote - Finviz
What is the current Price Target and Forecast for Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) - Zacks Investment Research
BVXV Financial Statements & ChartsScinai Immunotherapeutics LtdAdr MacroTrends - CMLviz
BVXV Pivot Points, Technical Analysis and Moving AveragesScinai Immunotherapeutics LtdAdr Technicals - CMLviz
SCNI Stock Price | Scinai Immunotherapeutics Ltd. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch
Finanzdaten der Scinai Immunotherapeutics Ltd Adr-Aktie (SCNI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):